BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3006736)

  • 1. c-Ki-ras amplification in human lung cancer.
    Heighway J; Hasleton PS
    Br J Cancer; 1986 Feb; 53(2):285-7. PubMed ID: 3006736
    [No Abstract]   [Full Text] [Related]  

  • 2. Amplification of oncogenes in lung carcinoma grafted in nude mice.
    Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
    Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and enhanced expression of cellular oncogene c-Ki-ras-2 in a human epidermoid carcinoma of the lung.
    Miyaki M; Sato C; Matsui T; Koike M; Mori T; Kosaki G; Takai S; Tonomura A; Tsuchida N
    Jpn J Cancer Res; 1985 Apr; 76(4):260-5. PubMed ID: 3924699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
    Saksela K; Bergh J; Nilsson K
    J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and genetic abnormalities in lung cancer.
    Carney DN
    Chest; 1989 Jul; 96(1 Suppl):25S-27S. PubMed ID: 2544354
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypomethylation of ras oncogenes in primary human cancers.
    Feinberg AP; Vogelstein B
    Biochem Biophys Res Commun; 1983 Feb; 111(1):47-54. PubMed ID: 6187346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
    Kiefer PE; Bepler G; Kubasch M; Havemann K
    Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.
    Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K
    Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of cellular DNA-RNA content using flow cytometry in primary lung carcinomas and its relationship to malignant intensity].
    Yamaoka N
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2252-64. PubMed ID: 2833548
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.
    Rodenhuis S; van de Wetering ML; Mooi WJ; Evers SG; van Zandwijk N; Bos JL
    N Engl J Med; 1987 Oct; 317(15):929-35. PubMed ID: 3041218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenes and tumor suppressor genes in human lung carcinogenesis.
    Iman DS; Harris CC
    Crit Rev Oncog; 1991; 2(2):161-71. PubMed ID: 1649643
    [No Abstract]   [Full Text] [Related]  

  • 12. Amplification, expression and rearrangement of c-myc and N-myc oncogenes in human lung cancer.
    Nau MM; Carney DN; Battey J; Johnson B; Little C; Gazdar A; Minna JD
    Curr Top Microbiol Immunol; 1984; 113():172-7. PubMed ID: 6090062
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.
    Weston A; Willey JC; Modali R; Sugimura H; McDowell EM; Resau J; Light B; Haugen A; Mann DL; Trump BF
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5099-103. PubMed ID: 2567993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amplification of the expression of the c-myc oncogene in bronchial epidermoid carcinoma in man].
    Douc-Rasy S; Terrier P; Kemeny JL; Amouroux J; Riou G
    C R Acad Sci III; 1985; 301(13):621-6. PubMed ID: 3937573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas.
    Schalken JA; Roebroek AJ; Oomen PP; Wagenaar SS; Debruyne FM; Bloemers HP; Van de Ven WJ
    J Clin Invest; 1987 Dec; 80(6):1545-9. PubMed ID: 2824565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung.
    Pelosi G; Fumagalli C; Trubia M; Sonzogni A; Rekhtman N; Maisonneuve P; Galetta D; Spaggiari L; Veronesi G; Scarpa A; Malpeli G; Viale G
    Anticancer Res; 2010 Oct; 30(10):4269-81. PubMed ID: 21036752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells.
    Hellmann GM; Fields WR; Doolittle DJ
    Toxicol Sci; 2001 May; 61(1):154-63. PubMed ID: 11294986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.
    Comtesse N; Keller A; Diesinger I; Bauer C; Kayser K; Huwer H; Lenhof HP; Meese E
    Int J Cancer; 2007 Jun; 120(12):2538-44. PubMed ID: 17290396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenes and a specific chromosomal abnormality associated with small-cell lung cancers.
    Taya Y
    Jpn J Clin Oncol; 1986 Sep; 16(3):199-202. PubMed ID: 3022029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.
    Berenson JR; Koga H; Yang J; Pearl J; Holmes EC; Figlin R
    Oncogene; 1990 Sep; 5(9):1343-8. PubMed ID: 2170896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.